Journal of Gastrointestinal Surgery, ISSN 1091-255X, 2006, Volume 10, Issue 10, pp. 1319 - 1329
Neoadjuvant chemoradiation therapy (CRT) is the preferred treatment option for distal rectal cancer. Complete pathological response after CRT has led to the...
recurrence | Rectal cancer | neoadjuvant therapy | survival | Medicine & Public Health | Surgery | Gastroenterology | SURGERY | PREOPERATIVE CHEMORADIATION | COMBINED-MODALITY THERAPY | RADICAL RESECTION | ADENOCARCINOMA | rectal cancer | TOTAL MESORECTAL EXCISION | PATHOLOGICAL COMPLETE RESPONSE | LOCAL RECURRENCE | COLORECTAL-CANCER | RADIOTHERAPY | GASTROENTEROLOGY & HEPATOLOGY | Radiotherapy Dosage | Humans | Middle Aged | Neoplasm Recurrence, Local | Male | Combined Modality Therapy | Rectal Neoplasms - therapy | Rectal Neoplasms - mortality | Rectal Neoplasms - radiotherapy | Disease-Free Survival | Fluorouracil - therapeutic use | Antimetabolites, Antineoplastic - therapeutic use | Survival Analysis | Female | Neoadjuvant Therapy | Aged | Rectal Neoplasms - pathology | Radiotherapy, Adjuvant | Rectal Neoplasms - drug therapy | Health aspects | Care and treatment | Cancer | Chemotherapy | Toxicity | Medical treatment
recurrence | Rectal cancer | neoadjuvant therapy | survival | Medicine & Public Health | Surgery | Gastroenterology | SURGERY | PREOPERATIVE CHEMORADIATION | COMBINED-MODALITY THERAPY | RADICAL RESECTION | ADENOCARCINOMA | rectal cancer | TOTAL MESORECTAL EXCISION | PATHOLOGICAL COMPLETE RESPONSE | LOCAL RECURRENCE | COLORECTAL-CANCER | RADIOTHERAPY | GASTROENTEROLOGY & HEPATOLOGY | Radiotherapy Dosage | Humans | Middle Aged | Neoplasm Recurrence, Local | Male | Combined Modality Therapy | Rectal Neoplasms - therapy | Rectal Neoplasms - mortality | Rectal Neoplasms - radiotherapy | Disease-Free Survival | Fluorouracil - therapeutic use | Antimetabolites, Antineoplastic - therapeutic use | Survival Analysis | Female | Neoadjuvant Therapy | Aged | Rectal Neoplasms - pathology | Radiotherapy, Adjuvant | Rectal Neoplasms - drug therapy | Health aspects | Care and treatment | Cancer | Chemotherapy | Toxicity | Medical treatment
Journal Article
Diseases of the Colon & Rectum, ISSN 0012-3706, 10/2013, Volume 56, Issue 10, pp. 1109 - 1117
BACKGROUND:No immediate surgery (Watch and Wait) has been considered in select patients with complete clinical response after neoadjuvant chemoradiation to...
Watch and wait | Neoadjuvant chemoradiation | Rectal cancer | Complete clinical response | SURVIVAL | SURGERY | PREOPERATIVE CHEMORADIATION | COMPLETE CLINICAL-RESPONSE | SEE POLICY | STAGE | CHEMORADIOTHERAPY | TRIAL | NONOPERATIVE MANAGEMENT | THERAPY | PREDICTORS | GASTROENTEROLOGY & HEPATOLOGY | Leucovorin - administration & dosage | Adenocarcinoma - pathology | Prospective Studies | Humans | Middle Aged | Male | Neoplasm Recurrence, Local - diagnosis | Chemoradiotherapy, Adjuvant | Rectal Neoplasms - therapy | Fluorouracil - administration & dosage | Adenocarcinoma - therapy | Time Factors | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged, 80 and over | Dose Fractionation | Female | Neoadjuvant Therapy | Watchful Waiting | Aged | Rectal Neoplasms - pathology | Neoplasm Staging
Watch and wait | Neoadjuvant chemoradiation | Rectal cancer | Complete clinical response | SURVIVAL | SURGERY | PREOPERATIVE CHEMORADIATION | COMPLETE CLINICAL-RESPONSE | SEE POLICY | STAGE | CHEMORADIOTHERAPY | TRIAL | NONOPERATIVE MANAGEMENT | THERAPY | PREDICTORS | GASTROENTEROLOGY & HEPATOLOGY | Leucovorin - administration & dosage | Adenocarcinoma - pathology | Prospective Studies | Humans | Middle Aged | Male | Neoplasm Recurrence, Local - diagnosis | Chemoradiotherapy, Adjuvant | Rectal Neoplasms - therapy | Fluorouracil - administration & dosage | Adenocarcinoma - therapy | Time Factors | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged, 80 and over | Dose Fractionation | Female | Neoadjuvant Therapy | Watchful Waiting | Aged | Rectal Neoplasms - pathology | Neoplasm Staging
Journal Article
Radiologia Brasileira, ISSN 0100-3984, 08/2010, Volume 43, Issue 4, pp. V - VI
Journal Article
Radiologia Brasileira, ISSN 0100-3984, 2010, Volume 43, Issue 4, pp. 5 - 6
Journal Article
Radiologia Brasileira, ISSN 0100-3984, 08/2010, Volume 43, Issue 4, pp. V - VI
Journal Article
Diseases of the Colon & Rectum, ISSN 0012-3706, 12/2009, Volume 52, Issue 12, pp. 1927 - 1934
OBJECTIVES:Addition of chemotherapy in the resting period between radiotherapy completion and response assessment during neoadjuvant treatment for distal...
Rectal cancer | Neoadjuvant therapy | Chemotherapy | INTERVAL | SURGERY | CHEMORADIATION THERAPY | FLUOROURACIL | PATHOLOGICAL COMPLETE RESPONSE | RADIATION-THERAPY | PREOPERATIVE RADIOTHERAPY | RECURRENCE | DISEASE-FREE SURVIVAL | NONOPERATIVE TREATMENT | GASTROENTEROLOGY & HEPATOLOGY | Radiotherapy Dosage | Leucovorin - administration & dosage | Adenocarcinoma - pathology | Humans | Middle Aged | Neoplasm Recurrence, Local | Male | Lymphatic Metastasis | Adenocarcinoma - drug therapy | Rectal Neoplasms - radiotherapy | Fluorouracil - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Female | Neoadjuvant Therapy | Rectal Neoplasms - pathology | Rectal Neoplasms - drug therapy | Adenocarcinoma - radiotherapy | Index Medicus
Rectal cancer | Neoadjuvant therapy | Chemotherapy | INTERVAL | SURGERY | CHEMORADIATION THERAPY | FLUOROURACIL | PATHOLOGICAL COMPLETE RESPONSE | RADIATION-THERAPY | PREOPERATIVE RADIOTHERAPY | RECURRENCE | DISEASE-FREE SURVIVAL | NONOPERATIVE TREATMENT | GASTROENTEROLOGY & HEPATOLOGY | Radiotherapy Dosage | Leucovorin - administration & dosage | Adenocarcinoma - pathology | Humans | Middle Aged | Neoplasm Recurrence, Local | Male | Lymphatic Metastasis | Adenocarcinoma - drug therapy | Rectal Neoplasms - radiotherapy | Fluorouracil - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Female | Neoadjuvant Therapy | Rectal Neoplasms - pathology | Rectal Neoplasms - drug therapy | Adenocarcinoma - radiotherapy | Index Medicus
Journal Article
Radiologia Brasileira, ISSN 0100-3984, 04/2009, Volume 42, Issue 2, pp. v - vi
Journal Article
Annals of Surgery, ISSN 0003-4932, 10/2004, Volume 240, Issue 4, pp. 711 - 718
Objective: Report overall long-term results of stage 0 rectal cancer following neoadjuvant chemoradiation and compare long-term results between operative and...
ADJUVANT CHEMOTHERAPY | SURGERY | ABDOMINOPERINEAL RESECTION | COMBINED-MODALITY THERAPY | PREOPERATIVE RADIOTHERAPY | ADENOCARCINOMA | COMPLETE RESPONSE | COLORECTAL-CARCINOMA | SPHINCTER PRESERVATION | TOTAL MESORECTAL EXCISION | RADIATION-THERAPY | Ileostomy | Follow-Up Studies | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Colostomy | Neoplasm Recurrence, Local - pathology | Fluorouracil - therapeutic use | Aged, 80 and over | Adult | Female | Leucovorin - therapeutic use | Neoadjuvant Therapy | Rectal Neoplasms - drug therapy | Adenocarcinoma - radiotherapy | Radiotherapy Dosage | Rectal Neoplasms - surgery | Survival Rate | Treatment Outcome | Adenocarcinoma - drug therapy | Remission Induction | Rectal Neoplasms - radiotherapy | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Aged | Neoplasm Staging | Longitudinal Studies | Adenocarcinoma - surgery | Original and Discussions
ADJUVANT CHEMOTHERAPY | SURGERY | ABDOMINOPERINEAL RESECTION | COMBINED-MODALITY THERAPY | PREOPERATIVE RADIOTHERAPY | ADENOCARCINOMA | COMPLETE RESPONSE | COLORECTAL-CARCINOMA | SPHINCTER PRESERVATION | TOTAL MESORECTAL EXCISION | RADIATION-THERAPY | Ileostomy | Follow-Up Studies | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Colostomy | Neoplasm Recurrence, Local - pathology | Fluorouracil - therapeutic use | Aged, 80 and over | Adult | Female | Leucovorin - therapeutic use | Neoadjuvant Therapy | Rectal Neoplasms - drug therapy | Adenocarcinoma - radiotherapy | Radiotherapy Dosage | Rectal Neoplasms - surgery | Survival Rate | Treatment Outcome | Adenocarcinoma - drug therapy | Remission Induction | Rectal Neoplasms - radiotherapy | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Aged | Neoplasm Staging | Longitudinal Studies | Adenocarcinoma - surgery | Original and Discussions
Journal Article
Radiologia Brasileira, ISSN 0100-3984, 04/2009, Volume 42, Issue 2, pp. v - vi
Journal Article
Journal of Gastrointestinal Surgery, ISSN 1091-255X, 2005, Volume 9, Issue 1, pp. 90 - 101
Neoadjuvant chemoradiation treatment (CRT) has resulted in significant tumor downstaging and improved local disease control for distal rectal cancer. The...
Rectal cancer | treatment | survival | Medicine & Public Health | Surgery | Gastroenterology | PROGNOSTIC IMPLICATIONS | SURGERY | RESECTION | ADENOCARCINOMA | rectal cancer | COMPLETE RESPONSE | COLORECTAL-CARCINOMA | SPHINCTER PRESERVATION | TOTAL MESORECTAL EXCISION | RADIATION-THERAPY | QUALITY-OF-LIFE | RADIOTHERAPY | GASTROENTEROLOGY & HEPATOLOGY | Adenocarcinoma - pathology | Rectal Neoplasms - surgery | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Remission Induction | Rectal Neoplasms - mortality | Fluorouracil - therapeutic use | Aged, 80 and over | Adult | Female | Leucovorin - therapeutic use | Neoadjuvant Therapy | Aged | Neoplasm Recurrence, Local - epidemiology | Rectal Neoplasms - pathology | Neoplasm Staging | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Clinical trials | Chemotherapy | Medical treatment
Rectal cancer | treatment | survival | Medicine & Public Health | Surgery | Gastroenterology | PROGNOSTIC IMPLICATIONS | SURGERY | RESECTION | ADENOCARCINOMA | rectal cancer | COMPLETE RESPONSE | COLORECTAL-CARCINOMA | SPHINCTER PRESERVATION | TOTAL MESORECTAL EXCISION | RADIATION-THERAPY | QUALITY-OF-LIFE | RADIOTHERAPY | GASTROENTEROLOGY & HEPATOLOGY | Adenocarcinoma - pathology | Rectal Neoplasms - surgery | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Remission Induction | Rectal Neoplasms - mortality | Fluorouracil - therapeutic use | Aged, 80 and over | Adult | Female | Leucovorin - therapeutic use | Neoadjuvant Therapy | Aged | Neoplasm Recurrence, Local - epidemiology | Rectal Neoplasms - pathology | Neoplasm Staging | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Clinical trials | Chemotherapy | Medical treatment
Journal Article
Radiologia Brasileira, ISSN 0100-3984, 03/2009, Volume 42, Issue 2, pp. 5 - 6
Journal Article
Radiation Oncology, ISSN 1748-717X, 07/2014, Volume 9, Issue 1, pp. 158 - 158
Background: Ototoxicity is a known side effect of combined radiation therapy and cisplatin chemotherapy for the treatment of medulloblastoma. The delivery of...
Intensity-modulated radiotherapy | Medulloblastoma | Cisplatin | Hearing loss | Quality of life | TUMOR-BED BOOST | AVERAGE-RISK MEDULLOBLASTOMA | SENSORINEURAL HEARING-LOSS | PATTERNS | CHEMOTHERAPY | BRAIN-TUMORS | CHILDREN | IRRADIATION | ONCOLOGY | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiotherapy Dosage | Hearing Loss - diagnosis | Prognosis | Follow-Up Studies | Hearing Loss - etiology | Humans | Radiation Tolerance | Child, Preschool | Infant | Male | Radiotherapy, Intensity-Modulated - adverse effects | Hearing - radiation effects | Young Adult | Medulloblastoma - radiotherapy | Adolescent | Adult | Female | Retrospective Studies | Cerebellar Neoplasms - radiotherapy | Child | Radiotherapy Planning, Computer-Assisted | Infant, Newborn | Comparative analysis | Information management | Oncology | Chemotherapy | Radiation therapy | Hearing impairment | Patients | Children & youth | Index Medicus
Intensity-modulated radiotherapy | Medulloblastoma | Cisplatin | Hearing loss | Quality of life | TUMOR-BED BOOST | AVERAGE-RISK MEDULLOBLASTOMA | SENSORINEURAL HEARING-LOSS | PATTERNS | CHEMOTHERAPY | BRAIN-TUMORS | CHILDREN | IRRADIATION | ONCOLOGY | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiotherapy Dosage | Hearing Loss - diagnosis | Prognosis | Follow-Up Studies | Hearing Loss - etiology | Humans | Radiation Tolerance | Child, Preschool | Infant | Male | Radiotherapy, Intensity-Modulated - adverse effects | Hearing - radiation effects | Young Adult | Medulloblastoma - radiotherapy | Adolescent | Adult | Female | Retrospective Studies | Cerebellar Neoplasms - radiotherapy | Child | Radiotherapy Planning, Computer-Assisted | Infant, Newborn | Comparative analysis | Information management | Oncology | Chemotherapy | Radiation therapy | Hearing impairment | Patients | Children & youth | Index Medicus
Journal Article
Radiologia Brasileira, ISSN 0100-3984, 09/2010, Volume 43, Issue 5, pp. 324 - 329
É sabido que o envelhecimento da população do mundo durante o século XX e no início deste novo século constitui um desafio de primeira ordem para as nações,...
Radiotherapy | Elderly | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Radiotherapy | Elderly | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Radiologia Brasileira, ISSN 0100-3984, 10/2010, Volume 43, Issue 5, pp. 324 - 329
É sabido que o envelhecimento da população do mundo durante o século XX e no início deste novo século constitui um desafio de primeira ordem para as nações,...
Idosos | Radiotherapy | Elderly | Radioterapia
Idosos | Radiotherapy | Elderly | Radioterapia
Journal Article
Radiologia Brasileira, ISSN 0100-3984, 10/2010, Volume 43, Issue 5, pp. 324 - 329
É sabido que o envelhecimento da população do mundo durante o século XX e no início deste novo século constitui um desafio de primeira ordem para as nações,...
Journal Article
Hepato-Gastroenterology, ISSN 0172-6390, 11/2004, Volume 51, Issue 60, pp. 1703 - 1707
Background/Aims: Multimodality treatment is the preferred strategy in the management of low rectal adenocarcinoma. Preoperative chemoradiation therapy (CRT)...
Rectal cancer | Chemoradiation | Downstaging | SURGERY | LOCAL EXCISION | RESECTION | rectal cancer | RISK | ADJUVANT THERAPY | RADIATION | CHEMOTHERAPY | PRESERVATION | RADIOCHEMOTHERAPY | RADIOTHERAPY | downstaging | chemoradiation | Immunohistochemistry | Follow-Up Studies | Risk Assessment | Humans | Middle Aged | Colectomy - methods | Male | Treatment Outcome | Anal Canal | Combined Modality Therapy | Rectal Neoplasms - therapy | Rectal Neoplasms - mortality | Survival Analysis | Adult | Female | Aged | Rectal Neoplasms - pathology | Retrospective Studies | Biopsy, Needle | Chemotherapy, Adjuvant | Neoplasm Staging | Radiotherapy, Adjuvant | Preoperative Care - methods
Rectal cancer | Chemoradiation | Downstaging | SURGERY | LOCAL EXCISION | RESECTION | rectal cancer | RISK | ADJUVANT THERAPY | RADIATION | CHEMOTHERAPY | PRESERVATION | RADIOCHEMOTHERAPY | RADIOTHERAPY | downstaging | chemoradiation | Immunohistochemistry | Follow-Up Studies | Risk Assessment | Humans | Middle Aged | Colectomy - methods | Male | Treatment Outcome | Anal Canal | Combined Modality Therapy | Rectal Neoplasms - therapy | Rectal Neoplasms - mortality | Survival Analysis | Adult | Female | Aged | Rectal Neoplasms - pathology | Retrospective Studies | Biopsy, Needle | Chemotherapy, Adjuvant | Neoplasm Staging | Radiotherapy, Adjuvant | Preoperative Care - methods
Journal Article
Journal of the American College of Surgeons, ISSN 1072-7515, 2008, Volume 207, Issue 3, pp. S20 - S20
Journal Article
Diseases of the Colon & Rectum, ISSN 0012-3706, 9/1998, Volume 41, Issue 9, pp. 1087 - 1096
INTRODUCTION: The aim of this study was to evaluate the impact of combined radiotherapy and chemotherapy (leucovorin and 5-fluorouracil) on the treatment of...
Sphincter-saving | Recurrence | Oncology | Radiotherapy | Survival | Chemotherapy | Medicine & Public Health | Colorectal Surgery | Surgery | Gastroenterology | Downstaging | Surgical Oncology | Low rectal cancer | Sphincter- saving | Low cancer | SURGERY | LEUCOVORIN | survival | sphincter-saving | COLORECTAL-CARCINOMA | FLUOROURACIL | chemotherapy | RANDOMIZED TRIAL | recurrence | 5-FLUOROURACIL | low rectal cancer | THERAPY | PREOPERATIVE IRRADIATION | radiotherapy | GASTROENTEROLOGY & HEPATOLOGY | downstaging | PHASE-I | Leucovorin - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Aged, 80 and over | Adult | Female | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Rectal Neoplasms - drug therapy | Adenocarcinoma - radiotherapy | Rectal Neoplasms - surgery | Survival Rate | Treatment Outcome | Combined Modality Therapy | Adenocarcinoma - drug therapy | Rectal Neoplasms - mortality | Rectal Neoplasms - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Anastomosis, Surgical | Aged | Adenocarcinoma - mortality | Adenocarcinoma - surgery
Sphincter-saving | Recurrence | Oncology | Radiotherapy | Survival | Chemotherapy | Medicine & Public Health | Colorectal Surgery | Surgery | Gastroenterology | Downstaging | Surgical Oncology | Low rectal cancer | Sphincter- saving | Low cancer | SURGERY | LEUCOVORIN | survival | sphincter-saving | COLORECTAL-CARCINOMA | FLUOROURACIL | chemotherapy | RANDOMIZED TRIAL | recurrence | 5-FLUOROURACIL | low rectal cancer | THERAPY | PREOPERATIVE IRRADIATION | radiotherapy | GASTROENTEROLOGY & HEPATOLOGY | downstaging | PHASE-I | Leucovorin - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Aged, 80 and over | Adult | Female | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Rectal Neoplasms - drug therapy | Adenocarcinoma - radiotherapy | Rectal Neoplasms - surgery | Survival Rate | Treatment Outcome | Combined Modality Therapy | Adenocarcinoma - drug therapy | Rectal Neoplasms - mortality | Rectal Neoplasms - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Anastomosis, Surgical | Aged | Adenocarcinoma - mortality | Adenocarcinoma - surgery
Journal Article
European Archives of Oto-Rhino-Laryngology, ISSN 0937-4477, 12/2007, Volume 264, Issue 12, pp. 1475 - 1482
Unresectable head and neck squamous cell carcinoma (HNSCC), non-metastatic, comprises a heterogeneous group of patients (pts), formed of stage III and IV pts....
Chemotherapy | Medicine & Public Health | Head and Neck Surgery | Head and neck cancer | Otorhinolaryngology | Neurosurgery | Radiotherapy | Cisplatin | head and neck cancer | PHASE-III | THERAPY ONCOLOGY GROUP | CHEMORADIOTHERAPY | RANDOMIZED CONTROLLED-TRIAL | chemotherapy | ACCELERATED FRACTIONATION | CANCER | RADIATION-THERAPY | RADIOCHEMOTHERAPY | OTORHINOLARYNGOLOGY | radiotherapy | LOCALLY ADVANCED HEAD | cisplatin | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Head and Neck Neoplasms - drug therapy | Male | Combined Modality Therapy | Antineoplastic Agents - administration & dosage | Carcinoma, Squamous Cell - radiotherapy | Cisplatin - administration & dosage | Feasibility Studies | Head and Neck Neoplasms - pathology | Dose-Response Relationship, Drug | Disease-Free Survival | Head and Neck Neoplasms - radiotherapy | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Agents - adverse effects | Cisplatin - adverse effects | Adult | Female | Aged | Neoplasm Staging | Cohort Studies | Antimitotic agents | Squamous cell carcinoma | Antineoplastic agents
Chemotherapy | Medicine & Public Health | Head and Neck Surgery | Head and neck cancer | Otorhinolaryngology | Neurosurgery | Radiotherapy | Cisplatin | head and neck cancer | PHASE-III | THERAPY ONCOLOGY GROUP | CHEMORADIOTHERAPY | RANDOMIZED CONTROLLED-TRIAL | chemotherapy | ACCELERATED FRACTIONATION | CANCER | RADIATION-THERAPY | RADIOCHEMOTHERAPY | OTORHINOLARYNGOLOGY | radiotherapy | LOCALLY ADVANCED HEAD | cisplatin | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Head and Neck Neoplasms - drug therapy | Male | Combined Modality Therapy | Antineoplastic Agents - administration & dosage | Carcinoma, Squamous Cell - radiotherapy | Cisplatin - administration & dosage | Feasibility Studies | Head and Neck Neoplasms - pathology | Dose-Response Relationship, Drug | Disease-Free Survival | Head and Neck Neoplasms - radiotherapy | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Agents - adverse effects | Cisplatin - adverse effects | Adult | Female | Aged | Neoplasm Staging | Cohort Studies | Antimitotic agents | Squamous cell carcinoma | Antineoplastic agents
Journal Article
Radiologia Brasileira, ISSN 0100-3984, 04/2004, Volume 37, Issue 2, pp. 100 - 100
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.